Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirk U Knowlton

Showing results (51-60 of 132) with videos related to

Pageof 14
Sort By:
Journal of Cardiovascular Electrophysiology|December 25, 2021
Economics and outcomes of sotalol in-patient dosing approaches in patients with atrial fibrillationDaniel L Varela, Tyson S Burnham, Heidi T May, et al.
European Journal of Preventive Cardiology|February 24, 2021
Association of periodic fasting lifestyles with survival and incident major adverse cardiovascular events in patients undergoing cardiac catheterizationCiera L Bartholomew, Joseph B Muhlestein, Jeffrey L Anderson, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 6, 2026
Cardiomyocyte β-arrestins mediate inflammation and cGAS-STING activation in CVB3 viral myocarditisEmilio Y Lucero, Haoran Jiang, Vincent D'Anniballe, et al.
Journal of Clinical Medicine|May 25, 2024
Contemporary Predictors of Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: A Nationally Representative US SampleBenjamin D Horne, Nipun Atreja, John Venditto, et al.
Journal of Cardiovascular Electrophysiology|September 30, 2017
Real world MRI experience with nonconditional and conditional cardiac rhythm devices after MagnaSafeSteve Mason, Jeffrey S Osborn, Ritesh Dhar, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 22, 2020
Spectrum of radionuclide perfusion study abnormalities in takotsubo cardiomyopathyJeffrey L Anderson, Benjamin D Horne, Viet T Le, et al.
American Heart Journal|November 19, 2021
Behavioral Nudges as Patient Decision Support for Medication Adherence: The ENCOURAGE Randomized Controlled TrialBenjamin D Horne, Joseph B Muhlestein, Donald L Lappé, et al.
JACC. Advances|June 28, 2024
Impact of Active vs Passive Statin Selection for Primary Prevention: The CorCal Vanguard TrialJeffrey L Anderson, Kirk U Knowlton, Heidi T May, et al.
Journal of Arrhythmia|December 16, 2022
Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non-valvular atrial fibrillation (cognitive decline and dementia in patients with non-valvular atrial fibrillation [CAF] trial)Thomas Jared Bunch, Heidi May, Michael Cutler, et al.
The Journal of Clinical Investigation|February 18, 2003
The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injuryHideo Yasukawa, Toshitaka Yajima, Hervé Duplain, et al.
Pageof 14

Showing results (51-60 of 132) with videos related to

Sort By:
Pageof 14
Journal of Cardiovascular Electrophysiology|December 25, 2021
Economics and outcomes of sotalol in-patient dosing approaches in patients with atrial fibrillationDaniel L Varela, Tyson S Burnham, Heidi T May, et al.
European Journal of Preventive Cardiology|February 24, 2021
Association of periodic fasting lifestyles with survival and incident major adverse cardiovascular events in patients undergoing cardiac catheterizationCiera L Bartholomew, Joseph B Muhlestein, Jeffrey L Anderson, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 6, 2026
Cardiomyocyte β-arrestins mediate inflammation and cGAS-STING activation in CVB3 viral myocarditisEmilio Y Lucero, Haoran Jiang, Vincent D'Anniballe, et al.
Journal of Clinical Medicine|May 25, 2024
Contemporary Predictors of Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: A Nationally Representative US SampleBenjamin D Horne, Nipun Atreja, John Venditto, et al.
Journal of Cardiovascular Electrophysiology|September 30, 2017
Real world MRI experience with nonconditional and conditional cardiac rhythm devices after MagnaSafeSteve Mason, Jeffrey S Osborn, Ritesh Dhar, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 22, 2020
Spectrum of radionuclide perfusion study abnormalities in takotsubo cardiomyopathyJeffrey L Anderson, Benjamin D Horne, Viet T Le, et al.
American Heart Journal|November 19, 2021
Behavioral Nudges as Patient Decision Support for Medication Adherence: The ENCOURAGE Randomized Controlled TrialBenjamin D Horne, Joseph B Muhlestein, Donald L Lappé, et al.
JACC. Advances|June 28, 2024
Impact of Active vs Passive Statin Selection for Primary Prevention: The CorCal Vanguard TrialJeffrey L Anderson, Kirk U Knowlton, Heidi T May, et al.
Journal of Arrhythmia|December 16, 2022
Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non-valvular atrial fibrillation (cognitive decline and dementia in patients with non-valvular atrial fibrillation [CAF] trial)Thomas Jared Bunch, Heidi May, Michael Cutler, et al.
The Journal of Clinical Investigation|February 18, 2003
The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injuryHideo Yasukawa, Toshitaka Yajima, Hervé Duplain, et al.
Pageof 14